US 11053314
Methods to eliminate cancer stem cells by targeting CD47
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 11053314 (Methods to eliminate cancer stem cells by targeting CD47) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jul 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K38/18, A61K39/00